14 results on '"E, Shmueli"'
Search Results
2. Multitoroidal Interconnects For Tightly Coupled Supercomputers
- Author
-
Y. Aridor, Tamar Domany, O. Goldshmidt, José E. Moreira, E. Shmueli, and Y. Kliteynik
- Subjects
Interconnection ,business.industry ,Computer science ,Distributed computing ,Fault tolerance ,Parallel computing ,Supercomputer ,Network topology ,Scheduling (computing) ,Software ,Computational Theory and Mathematics ,Hardware and Architecture ,Signal Processing ,Scalability ,Redundancy (engineering) ,Resource management ,Crossbar switch ,business - Abstract
The processing elements of many modern tightly coupled multicomputers are connected via mesh or toroidal networks. Such interconnects are simple and highly scalable, but suffer from high fragmentation, low utilization, and insufficient fault tolerance when the resources allocated to each job are dedicated. High-dimensional interconnects may be more efficient in certain cases, but are based on complex and expensive components and scale poorly. We present a novel hardware/software architectural approach that detaches the processing elements of the system from the interconnect and augments the traditional toroidal topology to provide additional connectivity options and additional link redundancy. We explore the properties of the new "multitoroidal" topology and the improvements it offers in resource utilization and failure tolerance. We present the results of extensive simulation studies to show that for practically important types of workloads, the resource utilization may be increased by 50 percent and, in certain cases, as much as 100 percent compared to toroidal machines and is, in fact, close to the theoretically optimal case of a full crossbar interconnect. The combined hardware/software architectural innovation is a major significant improvement in resource utilization on top of the state of the art in scheduling algorithm research. Also, multitoroidal multicomputers are able to work under link failure rates of 0.002 failures per week that would shut down toroidal machines. A variant of the multitoroidal architecture is implemented in the Blue Gene/L supercomputer.
- Published
- 2008
- Full Text
- View/download PDF
3. Resource allocation and utilization in the Blue Gene/L supercomputer
- Author
-
Tamar Domany, O. Goldshmidt, Yariv Aridor, José E. Moreira, and E. Shmueli
- Subjects
Network architecture ,ComputerSystemsOrganization_COMPUTERSYSTEMIMPLEMENTATION ,General Computer Science ,Computer science ,Operating system ,computer.software_genre ,Supercomputer ,computer ,Partition (database) ,Blue gene - Abstract
This paper describes partition allocation for parallel jobs in the Blue Gene®/L supercomputer. It describes the novel network architecture of the Blue Gene/L (BG/L) three-dimensional (3D) computati...
- Published
- 2005
- Full Text
- View/download PDF
4. Central nervous system progression among patients with metastatic breast cancer responding to trastuzumab treatment
- Author
-
Michael Inbar, N. Wigler, and E. Shmueli
- Subjects
Adult ,Oncology ,Cancer Research ,medicine.medical_specialty ,Pathology ,Systemic disease ,Mammary gland ,Central nervous system ,Antineoplastic Agents ,Breast Neoplasms ,Antibodies, Monoclonal, Humanized ,Metastasis ,Central Nervous System Neoplasms ,Breast cancer ,Trastuzumab ,Internal medicine ,medicine ,Humans ,skin and connective tissue diseases ,business.industry ,Antibodies, Monoclonal ,Middle Aged ,medicine.disease ,Metastatic breast cancer ,medicine.anatomical_structure ,Disease Progression ,Prophylactic cranial irradiation ,business ,medicine.drug - Abstract
Central nervous system (CNS) metastases from breast cancer are common and can present as the first or solitary site of disease progression. The CNS has been reported to act as a sanctuary site that denies access to many chemotherapeutic agents. We present here, a series of 10 metastatic breast cancer patients who developed CNS metastases after an initial response to trastuzumab treatment. Forty one patients with metastatic HER2-overexpressing breast cancer, without evidence of CNS involvement prior to the initiation of trastuzumab treatment, were followed during trastuzumab treatment. A neurological evaluation was performed in those patients who developed neurological signs or symptoms during the course of treatment. The clinical course and pattern of CNS involvement in these patients are discussed. Thirty two patients (78%) showed an initial response to trastuzumab treatment. Ten (31%) of the responding patients developed either isolated CNS relapse or concurrent CNS and systemic progression at a median of 43 weeks after the initiation of trastuzumab treatment. Trastuzumab as a single agent was continued following control of brain symptoms in three patients, two showed signs of systemic disease progression at 11 and 15 weeks following the diagnosis of CNS metastases, respectively. In two other patients, trastuzumab in combination with weekly chemotherapy was continued for more than 20 weeks after CNS relapse without evidence of disease progression. The incidence of CNS involvement in our group of patients was higher than expected. With more successful and prolonged systemic anti-tumour effects achieved by novel drug combinations, the risk of developing CNS metastases might be even greater. Evaluation of prophylactic cranial irradiation strategies might be studied for high-risk patients.
- Published
- 2004
- Full Text
- View/download PDF
5. Primary papillary serous carcinoma of the peritoneum in a man
- Author
-
D. Aderka, M. Inbar, E. Shmueli, I. Schwartz, and L. Leider-Trejo
- Subjects
Male ,Pathology ,medicine.medical_specialty ,endocrine system diseases ,Autopsy ,Peritoneum ,Antigens, Neoplasm ,medicine ,Humans ,Peritoneal Neoplasms ,Pelvis ,business.industry ,Serous membrane ,Hematology ,Middle Aged ,Carcinoma, Papillary ,female genital diseases and pregnancy complications ,body regions ,Mesothelium ,Serous fluid ,medicine.anatomical_structure ,Oncology ,CA-125 Antigen ,Abdomen ,Differential diagnosis ,business - Abstract
Summary Background Primary papillary serous carcinoma of the peritoneum is a well-known entity in women The tumour is derived from the extraovanan mesothelium and the pelvis and lower abdomen mesothelia The treatment strategies are similar to ovarian serous papillary carcinoma Patients and methods A case of primary serous papillary carcinoma of the peritoneum in a man is presented The patient, 53 years old, died 2 months after diagnosis Results The histologic and immunohistochemical studies of the tumour will be presented These studies, made during lifetime and at autopsy of the patient, confirm a diagnosis of primary serous papillary carcinoma of the peritoneum Conclusions primary serous papillary carcinoma of the peritoneum can occur in men, and should be considered in the differential diagnosis in cases of abdominal carcinomatosis of unknown origin Treatment options remain to be determined
- Published
- 2001
- Full Text
- View/download PDF
6. High insulin-like growth factor binding protein 1 levels in cirrhosis: Link with insulin resistance
- Author
-
E. Shmueli, Christopher O. Record, J. P. Miell, K. G. M. M. Alberti, and M. Stewart
- Subjects
Adult ,Blood Glucose ,Male ,medicine.medical_specialty ,Cirrhosis ,Biopsy ,medicine.medical_treatment ,Glucose uptake ,Insulin-like growth factor-binding protein ,Insulin resistance ,Liver Cirrhosis, Alcoholic ,Reference Values ,Internal medicine ,medicine ,Humans ,Insulin ,Insulin-Like Growth Factor I ,Hepatology ,biology ,business.industry ,Middle Aged ,Glucose clamp technique ,medicine.disease ,Growth hormone secretion ,Insulin-Like Growth Factor Binding Protein 1 ,Insulin-Like Growth Factor Binding Protein 3 ,Endocrinology ,Somatostatin ,Liver ,Growth Hormone ,Glucose Clamp Technique ,biology.protein ,Insulin Resistance ,business ,Biomarkers - Abstract
Hyperinsulinemic euglycemic clamps were performed on six patients with compensated alcoholic cirrhosis and on six normal comparison subjects. As in previous studies, glucose uptake in the cirrhotic patients was only 21% of the comparison value. The cirrhotic patients had high growth hormone (GH) and low insulin-like growth factor-I (IGF-I) levels, with low insulin-like growth factor-binding protein (IGFBP)-3 levels, but surprisingly high IGFBP-I levels (26.8 +/- 8.4 microgH vs. 3.2 +/- 0.2 microm/L, P < .001). The log IGFBP-1 level was inversely correlated with the log insulin sensitivity (r = -.95). The clamps were repeated with a somatostatin infusion to suppress GH secretion. IGFBP-1 increased in both groups, especially in the cirrhotic subjects. Insulin sensitivity increased in the normal subjects but was unchanged in the cirrhotic patients. Following GH treatment (0.13 U/kg/d for 5 days), the clamps were repeated. GH, IGF-1, and IGFBP-3 levels were now similar in the two groups; IGFBP-1 levels decreased in the cirrhotic patients but remained fivefold higher than the comparison value (10.6 +/- 3.7 vs. 2.1 +/- 0.4, P < .05). Glucose uptake in the cirrhotic patients remained only 29% of the comparison value, but the change in their insulin sensitivity was inversely correlated with the change in their IGFB-1 levels (r = -.84). These results suggests an important role for IGFBP-1 in modulating insulin sensitivity in cirrhosis.
- Published
- 1996
- Full Text
- View/download PDF
7. High insulin-like growth factor binding protein 1 levels in cirrhosis: Link with insulin resistance
- Author
-
E Shmueli
- Subjects
Hepatology - Published
- 1996
- Full Text
- View/download PDF
8. Octreotide Treatment Does Not Improve Impaired Glucose Uptake in Cirrhosis
- Author
-
E. Shmueli, H. Ørskov, C. O. Record, and K. G. M. M. Alberti
- Subjects
Adult ,Blood Glucose ,Liver Cirrhosis ,Male ,medicine.medical_specialty ,Cirrhosis ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,Glucose uptake ,Clinical Biochemistry ,Octreotide ,Fatty Acids, Nonesterified ,Biochemistry ,Endocrinology ,Insulin resistance ,Internal medicine ,medicine ,Humans ,Insulin ,Pancreatic hormone ,Glucose tolerance test ,C-Peptide ,medicine.diagnostic_test ,business.industry ,Biochemistry (medical) ,Fasting ,General Medicine ,Middle Aged ,medicine.disease ,Somatostatin ,Glucose Clamp Technique ,Insulin Resistance ,business ,medicine.drug - Abstract
Forearm glucose uptake during a hyperglycaemic (10 mmol/l) glucose clamp was diminished to 33% of the normal value (p = 0.012) in six cirrhotic patients compared with matched control subjects. Fasting insulin concentrations were significantly elevated in the cirrhotic patients confirming insulin resistance which may have been induced by chronic hyperinsulinaemia. The cirrhotic patients received one week of treatment with 50 micrograms octreotide subcutaneously three times daily which reduced pre-dose fasting insulin levels from 26.2 +/- 7.9 to 18.1 +/- 6.2 mU/l p < 0.005, and post dose levels to 7.0 +/- 3.5 mU/l p < 0.005. However when the glucose clamp was repeated 20 hours after the last dose of octreotide no change was detected in clamp glucose requirements, forearm glucose uptake, or stimulated insulin secretion. It was concluded that one week of lowering insulin levels does not reverse the insulin resistance of cirrhosis.
- Published
- 1993
- Full Text
- View/download PDF
9. Combination of laser treatment and intraluminal radiotherapy for malignant dysphagia
- Author
-
P. J. D. K. Dawes, K. Matthewson, E. Shmueli, M. Clague, Christopher O. Record, and E. Srivastava
- Subjects
medicine.medical_specialty ,Palliative care ,Esophageal Neoplasms ,medicine.medical_treatment ,Brachytherapy ,Adenocarcinoma ,medicine ,Carcinoma ,Humans ,Esophagus ,Aged ,Aged, 80 and over ,Esophageal disease ,business.industry ,Palliative Care ,Gastroenterology ,Middle Aged ,medicine.disease ,Combined Modality Therapy ,Survival Analysis ,Dysphagia ,Surgery ,Radiation therapy ,Treatment Outcome ,medicine.anatomical_structure ,Carcinoma, Squamous Cell ,Laser Therapy ,Radiology ,medicine.symptom ,Deglutition Disorders ,Complication ,business ,Research Article - Abstract
BACKGROUND: Laser treatment for malignant dysphagia is limited by recurrent intraluminal tumour requiring repeated treatment at four to eight week intervals. AIMS: To reduce the need for follow up treatment and to improve survival, patients successfully palliated by laser were treated with intraluminal radiotherapy. PATIENTS: 32 patients with inoperable oesophageal carcinoma (18 adeno and 14 squamous cell carcinoma). METHODS: The patients were initially palliated by a median of three laser treatments. They were then treated with intraluminal radiotherapy, receiving 10-15 Gy at 1 cm from the source as a single treatment with the Selectron system. Patients with squamous cell carcinoma also received external radiotherapy (30 to 50 Gy). RESULTS: After the radiotherapy nine patients survived a median of 22 (range 4-40) weeks without requiring any further endoscopic treatment. The remaining patients survived a median of 40 (range 4-102) weeks and required a median of three follow up endoscopic treatments over that time. Eleven patients developed fibrous strictures with no intraluminal tumour and were treated by dilatation. Twelve patients required dilatation and repeat laser therapy for a combination of fibrous stricture and recurrent intraluminal tumour. Six patients eventually required Atkinson tubes. CONCLUSIONS: The combination of laser treatment with intraluminal radiotherapy provides good palliation and may reduce the need for repeated endoscopic treatment. Fibrous stricture formation is a common complication.
- Published
- 1996
- Full Text
- View/download PDF
10. Limitations of laser treatment for malignant dysphagia
- Author
-
M. F. Myszor, D. A. Burke, Christopher O. Record, E. Shmueli, and K. Matthewson
- Subjects
Adult ,medicine.medical_specialty ,medicine.medical_treatment ,Adenocarcinoma ,Recurrence ,medicine ,Humans ,Intubation ,Aged ,Aged, 80 and over ,Laser Coagulation ,Esophageal disease ,business.industry ,Laser treatment ,Mortality rate ,Palliative Care ,Middle Aged ,medicine.disease ,Dysphagia ,Surgery ,Radiation therapy ,Treatment Outcome ,Carcinoma, Squamous Cell ,medicine.symptom ,Deglutition Disorders ,Complication ,business ,Follow-Up Studies ,Malignant dysphagia - Abstract
Of 86 patients with inoperable malignant dysphagia, 68 (79 per cent) underwent successful palliation by endoscopic laser therapy, of whom 24 remained well palliated until the time of death. In 18 patients laser treatment was unsuccessful and nine of these underwent intubation, eight successfully. After successful laser therapy, dysphagia recurred in 44 patients a mean of 7.8 weeks later. Of these, 31 received palliation until death by dilatation with or without laser therapy, and 13 required intubation. The overall laser-related complication rate was 12 per cent with a mortality rate of 4 per cent. The intubation-related mortality rate was 9 per cent.
- Published
- 1992
- Full Text
- View/download PDF
11. The complete DNA sequence and genome organization of the avian adenovirus, hemorrhagic enteritis virus
- Author
-
J. Pitcovski, Z. Rei-Koren, Y. Peretz, M. Mualem, E. Shmueli, S. Krispel, B. Gutter, G Gallili, D. Goldberg, and Amnon Michael
- Subjects
Turkeys ,Genes, Viral ,Avian adenovirus ,Molecular Sequence Data ,Genome, Viral ,Biology ,Genome ,DNA sequencing ,Adenoviridae ,Sequence-tagged site ,chemistry.chemical_compound ,Open Reading Frames ,Viral Proteins ,Virology ,Sequence Homology, Nucleic Acid ,Endopeptidases ,Animals ,Humans ,Amino Acid Sequence ,Gene ,Genomic organization ,Genetics ,Base Sequence ,Sequence Homology, Amino Acid ,Aviadenovirus ,Terminal Repeat Sequences ,biology.organism_classification ,chemistry ,DNA, Viral ,Human genome ,DNA - Abstract
Hemorrhagic enteritis virus (HEV) belongs to the Adenoviridae family, a subgroup of adenoviruses (Ads) that infect avian species. In this article, the complete DNA sequence and the genome organization of the virus are described. The full-length of the genome was found to be 26,263 bp, shorter than the DNA of any other Ad described so far. The G + C content of the genome is 34.93%. There are short terminal repeats (39 bp), as described for other Ads. Genes were identified by comparison of the DNA and predicted amino acid sequences with published sequences of other Ads. The organization of the genome in respect to late genes (52K, IIIa, penton base, core protein, hexon, endopeptidase, 100K, pVIII, and fiber), early region 2 genes (polymerase, terminal protein, and DNA binding protein), and intermediate gene IVa2 was found to be similar to that of other human and avian Ad genomes. No sequences similar to E1 and E4 regions were found. Very low similarity to ovine E3 region was found. Open reading frames were identified with no similarity to any published Ad sequence.
- Published
- 1998
12. Growth hormone, insulin-like growth factor-1 and insulin resistance in cirrhosis
- Author
-
E, Shmueli, M, Stewart, K G, Alberti, and C O, Record
- Subjects
Adult ,Male ,C-Peptide ,Calorimetry, Indirect ,Fatty Acids, Nonesterified ,Middle Aged ,Glucose ,Liver ,Liver Cirrhosis, Alcoholic ,Growth Hormone ,Glucose Clamp Technique ,Humans ,Insulin Resistance ,Insulin-Like Growth Factor I ,Somatostatin - Abstract
Cirrhosis is characterized by paradoxical growth hormone secretion in response to glucose and insulin infusion. To ascertain whether this abnormality contributes to insulin resistance, euglycemic hyperinsulinemic glucose clamps were performed on six patients with cirrhosis and six normal control subjects. Each patient with cirrhosis underwent two clamps in random order, a clamp with somatostatin (250 micrograms/hr) together with insulin and glucagon replacement, and a control clamp without somatostatin. The normal subjects underwent the control clamp only. During the control clamp, growth hormone levels were considerably higher in the patients with cirrhosis (6.1 +/- 0.4 vs. 0.5 +/- 0.4 mU/L, p0.02), and glucose uptake was considerably lower (3.29 +/- 0.56 vs. 9.52 +/- 1.14 mg/kg/min, p0.001). Indirect calorimetry indicated that the defect was accounted for by lower nonoxidative glucose disposal (1.23 +/- 0.45 vs. 6.00 +/- 0.73, p0.001). Peripheral glucose uptake, exemplified by forearm glucose uptake (0.27 +/- 0.04 vs. 1.22 +/- 0.42 mg/100 ml/min, p0.02), and calculated insulin sensitivity (24 +/- 8 vs. 114 +/- 20 microliters/kg/min per mU/L) were particularly diminished. In the patients with cirrhosis somatostatin suppressed growth hormone levels (6.1 +/- 1.2 to 1.2 +/- 0.4 mU/L, p0.05). However, no significant changes occurred in whole-body glucose uptake (3.29 +/- 0.56 vs 3.01 +/- 0.54 mg/kg/min), forearm glucose uptake (0.27 +/- 0.04 vs 0.30 +/- 0.01 mg/100 ml/min) or insulin sensitivity (24 +/- 8 vs, 35 +/- 10 microliters/kg/min/mU/L, p = 0.42).(ABSTRACT TRUNCATED AT 250 WORDS)
- Published
- 1994
13. Stomatal Infiltration Measurements as an Indicator of the Water Requirement and Timing of Irrigation for Cotton
- Author
-
M. Ofir, E. Shmueli, and S. Moreshet
- Subjects
Irrigation ,Infiltration (hydrology) ,Field practice ,Agronomy ,Irrigation control ,Environmental science ,Agronomy and Crop Science ,Water content ,Water requirement - Abstract
SUMMARYThe single-liquid infiltration method of measuring stomatal opening was adapted as a practical field method for determining the time of irrigation of cotton. A number of different liquids, leaf positions and times of measurement were tested and the most sensitive method was selected on the basis of the results. No stomatal response was found while soil moisture was depleted to one-third of available water. A steep reduction in stomatal opening was observed with further drying of the soil. Some results are presented from an irrigation experiment where irrigation control by infiltration method was compared with other methods. The practical possibilities in the use of the method in field practice are discussed.
- Published
- 1968
- Full Text
- View/download PDF
14. Data on cytogenetic registers
- Author
-
J. Dagan, A.E. Greene, Joseph L. Goldstein, G. Kohn, H.O. Dunn, J.R. Diamond, E. Shmueli, George M. Martin, C.W. Gray, Thomas H. Norwood, C.M. Croce, C.J. Chern, M.M. Cohen, K. Au, M. Shaham, Doris H. Wurster-Hill, Holger Hoehn, L.L. Coriell, H. Boman, Eileen Bryant, W.M. Howell, and Michael S. Brown
- Subjects
Genetics ,Computational biology ,Biology ,Molecular Biology ,Genetics (clinical) - Published
- 1975
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.